Ricardo
Torres Peral
Profesor Asociado CC. Salud
Hospital Infantil Universitario Niño Jesus de Madrid
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital Infantil Universitario Niño Jesus de Madrid (7)
2024
-
Blood gene expression biomarkers of response to anti-TNF drugs in pediatric inflammatory bowel diseases before initiation of treatment
Biomedicine and Pharmacotherapy, Vol. 173
2023
-
Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2021
-
Correction to: Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicenter Spanish study (European Journal of Pediatrics, (2021), 180, 9, (3029-3038), 10.1007/s00431-021-04063-6)
European Journal of Pediatrics
-
Safety and effectiveness of vedolizumab in paediatric patients with inflammatory bowel disease: an observational multicentre Spanish study
European Journal of Pediatrics, Vol. 180, Núm. 9, pp. 3029-3038
2020
-
Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease
Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515
2014
-
The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25years (1985-2009): The EXPERIENCE registry
Journal of Crohn's and Colitis, Vol. 8, Núm. 8, pp. 763-769
2013
-
Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): The SPIRIT registry
Inflammatory Bowel Diseases, Vol. 19, Núm. 1, pp. 73-80